• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低强度冲击波疗法治疗勃起功能障碍。

Low-Intensity Shockwave Therapy for Erectile Dysfunction.

机构信息

Baylor College of Medicine, Houston, TX, USA.

Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX, USA; Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA.

出版信息

Sex Med Rev. 2018 Oct;6(4):624-630. doi: 10.1016/j.sxmr.2018.01.002. Epub 2018 Mar 22.

DOI:10.1016/j.sxmr.2018.01.002
PMID:29576441
Abstract

BACKGROUND

Vasculogenic erectile dysfunction (ED) is one of the leading causes of male sexual dysfunction. In the past decade, multiple studies have examined the use of low-intensity extracorporeal shockwave therapy (Li-ESWT) for the treatment of ED.

AIM

Investigate the efficacy of Li-ESWT for the treatment of ED.

METHODS

We reviewed the published literature, including randomized controlled trials (RCTs), meta-analyses, and select single-arm studies on the use of Li-ESWT for the treatment of ED.

OUTCOMES

Changes in International Index of Erectile Function scores were evaluated in patients undergoing Li-ESWT.

RESULTS

There is no consensus from RCTs on the efficacy of Li-ESWT for the treatment of ED. Published meta-analyses have shown significant improvement in International Index of Erectile Function-erectile function domain scores in men undergoing Li-ESWT, especially when compared to men receiving sham treatment. However, differences in treatment protocols limit the generalizability of these findings. Li-ESWT may be more beneficial in cases of mild ED or when combined with phosphodiesterase type 5 inhibitors in men with moderate to severe ED. The role of Li-ESWT in the treatment of non-vasculogenic ED remains poorly defined.

CONCLUSIONS

Li-ESWT could be beneficial in specific sub-sets of men with vasculogenic ED. However, future RCTs should attempt to optimize treatment protocols and have more stringent inclusion criteria to confirm these findings. Rizk PJ, Krieger JR, Kohn TP, et al. Low-Intensity Shockwave Therapy for Erectile Dysfunction. Sex Med Rev 2018;6:624-630.

摘要

背景

血管性勃起功能障碍(ED)是男性性功能障碍的主要原因之一。在过去的十年中,多项研究已经检查了低强度体外冲击波疗法(Li-ESWT)治疗 ED 的应用。

目的

研究 Li-ESWT 治疗 ED 的疗效。

方法

我们回顾了已发表的文献,包括随机对照试验(RCT)、荟萃分析以及关于 Li-ESWT 治疗 ED 的选择单臂研究。

结局

评估接受 Li-ESWT 治疗的患者的国际勃起功能指数评分的变化。

结果

RCT 对 Li-ESWT 治疗 ED 的疗效没有共识。已发表的荟萃分析显示,接受 Li-ESWT 的男性的国际勃起功能指数-勃起功能域评分有显著改善,尤其是与接受假治疗的男性相比。然而,治疗方案的差异限制了这些发现的普遍性。Li-ESWT 可能对轻度 ED 或在中重度 ED 男性中与磷酸二酯酶 5 抑制剂联合使用时更有益。Li-ESWT 在治疗非血管性 ED 中的作用仍定义不明确。

结论

Li-ESWT 可能对特定的血管性 ED 男性亚组有益。然而,未来的 RCT 应尝试优化治疗方案并制定更严格的纳入标准,以证实这些发现。Rizk PJ, Krieger JR, Kohn TP, 等。低强度冲击波治疗勃起功能障碍。性医学评论 2018;6:624-630。

相似文献

1
Low-Intensity Shockwave Therapy for Erectile Dysfunction.低强度冲击波疗法治疗勃起功能障碍。
Sex Med Rev. 2018 Oct;6(4):624-630. doi: 10.1016/j.sxmr.2018.01.002. Epub 2018 Mar 22.
2
Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis.低强度体外冲击波治疗改善勃起功能:系统评价和荟萃分析。
Eur Urol. 2017 Feb;71(2):223-233. doi: 10.1016/j.eururo.2016.05.050. Epub 2016 Jun 16.
3
Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction in Diabetic Patients.低强度体外冲击波治疗糖尿病患者勃起功能障碍。
Sex Med Rev. 2021 Oct;9(4):619-627. doi: 10.1016/j.sxmr.2019.06.007. Epub 2019 Aug 1.
4
The Basic Science Behind Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Scoping Review of Pre-Clinical Studies.低强度体外冲击波治疗勃起功能障碍的基础科学:临床前研究的系统范围综述。
J Sex Med. 2019 Feb;16(2):168-194. doi: 10.1016/j.jsxm.2018.12.016.
5
Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients With Vasculogenic Erectile Dysfunction: A Triplex Ultrasonography-Based Sham-Controlled Trial.低强度冲击波疗法改善血管性勃起功能障碍患者的血流动力学参数:一项基于经颅多普勒超声的假对照试验。
J Sex Med. 2017 Jul;14(7):891-897. doi: 10.1016/j.jsxm.2017.05.012.
6
Effects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis.低强度体外冲击波疗法对勃起功能障碍的影响:一项系统评价和荟萃分析
J Sex Med. 2017 Jan;14(1):27-35. doi: 10.1016/j.jsxm.2016.11.001. Epub 2016 Dec 13.
7
Effect of Low-Intensity Extracorporeal Shock Wave on the Treatment of Erectile Dysfunction: A Systematic Review and Meta-Analysis.低强度体外冲击波治疗勃起功能障碍的疗效:系统评价和荟萃分析。
Am J Mens Health. 2019 Mar-Apr;13(2):1557988319846749. doi: 10.1177/1557988319846749.
8
Review of the Current Status of Low Intensity Extracorporeal Shockwave Therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie's Disease (PD), and Sexual Rehabilitation After Radical Prostatectomy With Special Focus on Technical Aspects of the Different Marketed ESWT Devices Including Personal Experiences in 350 Patients.低强度体外冲击波疗法(Li-ESWT)在勃起功能障碍(ED)、佩罗尼氏病(PD)及前列腺癌根治术后性康复中的现状综述,特别关注不同市售ESWT设备的技术方面,包括350例患者的个人经验
Sex Med Rev. 2021 Jan;9(1):93-122. doi: 10.1016/j.sxmr.2020.01.006. Epub 2020 Jun 2.
9
The Basic Physics of Waves, Soundwaves, and Shockwaves for Erectile Dysfunction.波的基础物理学、声波和冲击波在勃起功能障碍中的应用。
Sex Med Rev. 2020 Jan;8(1):100-105. doi: 10.1016/j.sxmr.2019.09.004. Epub 2019 Nov 14.
10
Low-intensity extracorporeal shockwave therapy for diabetic men with erectile dysfunction: A systematic scoping review.低强度体外冲击波治疗糖尿病伴勃起功能障碍男性:系统范围综述。
Andrology. 2023 Feb;11(2):270-281. doi: 10.1111/andr.13197. Epub 2022 Jun 8.

引用本文的文献

1
Efficacy, Satisfaction, and Safety of Low-Intensity, Large-Area Shock Wave Therapy With Dual-Probe Energy Delivery for Erectile Dysfunction.双探头能量传递低强度大面积冲击波疗法治疗勃起功能障碍的疗效、满意度及安全性
Cureus. 2025 May 3;17(5):e83389. doi: 10.7759/cureus.83389. eCollection 2025 May.
2
Effects of Extracorporeal Shockwave Therapy on Wound Healing in Rats.体外冲击波疗法对大鼠伤口愈合的影响。
Cureus. 2025 May 2;17(5):e83369. doi: 10.7759/cureus.83369. eCollection 2025 May.
3
An update on the use of stem cell therapy for erectile dysfunction.
干细胞疗法治疗勃起功能障碍的最新进展。
Asian J Urol. 2024 Oct;11(4):530-544. doi: 10.1016/j.ajur.2023.07.005. Epub 2024 Mar 11.
4
An overview of the Canadian landscape on the use of restorative therapies for erectile dysfunction and Peyronie's disease.加拿大使用恢复性疗法治疗勃起功能障碍和佩罗尼氏病的情况概述。
Can Urol Assoc J. 2024 Dec;18(12):420-424. doi: 10.5489/cuaj.8804.
5
Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up.低强度体外冲击波疗法治疗慢性盆腔疼痛综合征:长期随访
Open Med (Wars). 2023 Oct 28;18(1):20230832. doi: 10.1515/med-2023-0832. eCollection 2023.
6
The use of low-intensity extracorporeal shockwave therapy in management of erectile dysfunction following prostate cancer treatment: a review of the current literature.低强度体外冲击波疗法在前列腺癌治疗后勃起功能障碍管理中的应用:当前文献综述
Transl Androl Urol. 2023 Jun 30;12(6):1023-1032. doi: 10.21037/tau-22-791. Epub 2023 May 22.
7
Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data.重复使用肉毒杆菌毒素 A 海绵体内注射治疗对已批准药物治疗反应不佳的勃起功能障碍男性的安全性和有效性:真实世界观察数据。
Toxins (Basel). 2023 Jun 5;15(6):382. doi: 10.3390/toxins15060382.
8
Electroacupuncture for psychogenic erectile dysfunction: A resting-state functional magnetic resonance imaging study exploring the alteration of fractional amplitude of low frequency fluctuation.电针治疗心因性勃起功能障碍:一项基于静息态功能磁共振成像的低频振幅分数改变的探索性研究
Front Hum Neurosci. 2023 Mar 30;17:1116202. doi: 10.3389/fnhum.2023.1116202. eCollection 2023.
9
Systematic Review and Meta-Analysis of 16 Randomized Controlled Trials of Clinical Outcomes of Low-Intensity Extracorporeal Shock Wave Therapy in Treating Erectile Dysfunction.16 项低强度体外冲击波治疗勃起功能障碍的随机对照临床试验临床结局的系统评价和荟萃分析。
Am J Mens Health. 2022 Mar-Apr;16(2):15579883221087532. doi: 10.1177/15579883221087532.
10
Efficacy of Penile Low-Intensity Shockwave Therapy and Determinants of Treatment Response in Taiwanese Patients with Erectile Dysfunction.台湾勃起功能障碍患者阴茎低强度冲击波治疗的疗效及治疗反应的决定因素
Biomedicines. 2021 Nov 12;9(11):1670. doi: 10.3390/biomedicines9111670.